Abstract
The preparation of chiral tetrahydroquinolines using Ir-catalysed asymmetric hydrogenation and their possible cytotoxic potential anti-cancer activity were reported. Both of the in vitro cytotoxicity assay on a series of human cancer cell lines including A549 small cell lung cancer, MDA-MB-231 breast cancer, SaoS2 sacroma, SKHep-1 hepatoma and Hep3B hepatocellular carcinoma as well as in vivo animal model using Hep3B hepatocellular tumour xenograft on athymic nude mice suggest that 1,2,3,4-tetrahydroquin-8-ol is a potential anti-tumour alkaloid which may be further developed as a novel cancer chemotherapeutic agent.
Original language | English |
---|---|
Pages (from-to) | 166-171 |
Number of pages | 6 |
Journal | Phytomedicine |
Volume | 20 |
Issue number | 2 |
DOIs | |
Publication status | Published - 15 Jan 2013 |
Scopus Subject Areas
- Molecular Medicine
- Pharmacology
- Pharmaceutical Science
- Drug Discovery
- Complementary and alternative medicine
User-Defined Keywords
- Cancer cells
- Galipea officinalis
- Tetrahydroquinoline alkaloid
- Xenograft